Total Payments
$59,706
2024 Payments
$39,774
Companies
11
Transactions
70
Medicare Patients
107
Medicare Billing
$15,806
Payment Breakdown by Category
Other$39,091 (65.5%)
Consulting$15,975 (26.8%)
Food & Beverage$2,636 (4.4%)
Travel$1,911 (3.2%)
Education$93.22 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for a medical education program | $26,691 | 12 | 44.7% |
| Consulting Fee | $15,975 | 6 | 26.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,400 | 4 | 20.8% |
| Food and Beverage | $2,636 | 38 | 4.4% |
| Travel and Lodging | $1,911 | 8 | 3.2% |
| Education | $93.22 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $35,214 | 25 | $0 (2024) |
| GlaxoSmithKline, LLC. | $13,512 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $6,695 | 8 | $0 (2024) |
| Seagen Inc. | $2,192 | 3 | $0 (2023) |
| PFIZER INC. | $1,656 | 4 | $0 (2024) |
| ABBVIE INC. | $134.99 | 1 | $0 (2024) |
| Baxter Healthcare | $133.17 | 2 | $0 (2023) |
| ImmunoGen, Inc. | $70.47 | 1 | $0 (2024) |
| TESARO, Inc. | $61.03 | 1 | $0 (2019) |
| Clovis Oncology, Inc. | $20.01 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39,774 | 32 | Eisai Inc. ($31,414) |
| 2023 | $16,817 | 20 | GlaxoSmithKline, LLC. ($13,030) |
| 2022 | $2,628 | 10 | Seagen Inc. ($2,100) |
| 2021 | $425.24 | 7 | GlaxoSmithKline, LLC. ($214.20) |
| 2019 | $61.03 | 1 | TESARO, Inc. ($61.03) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,911.25 | General |
| 11/08/2024 | PFIZER INC. | TIVDAK (Biological) | Travel and Lodging | In-kind items and services | $725.85 | General |
| Category: Oncology | ||||||
| 11/08/2024 | PFIZER INC. | TIVDAK (Biological) | Travel and Lodging | In-kind items and services | $454.29 | General |
| Category: Oncology | ||||||
| 11/08/2024 | PFIZER INC. | TIVDAK (Biological) | Travel and Lodging | In-kind items and services | $349.00 | General |
| Category: Oncology | ||||||
| 11/08/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $126.57 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Eisai Inc. | Lenvima (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $815.00 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Eisai Inc. | Lenvima (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,520.00 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Eisai Inc. | Lenvima (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,037.50 | General |
| Category: Oncology | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Consulting Fee | Cash or cash equivalent | $3,425.00 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Eisai Inc. | Lenvima (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,445.00 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Eisai Inc. | Lenvima (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,445.00 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Eisai Inc. | Lenvima (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,037.50 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Eisai Inc. | Lenvima (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,037.50 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Eisai Inc. | Lenvima (Drug) | Travel and Lodging | Cash or cash equivalent | $171.91 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $77.49 | General |
| Category: Oncology | ||||||
| 08/22/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2024 | Eisai Inc. | Lenvima (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,445.00 | General |
| Category: Oncology | ||||||
| 08/01/2024 | Eisai Inc. | Lenvima (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,037.50 | General |
| Category: Oncology | ||||||
| 08/01/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $72.00 | General |
| Category: Oncology | ||||||
| 06/28/2024 | AstraZeneca Pharmaceuticals LP | ONGLYZA (Drug) | Food and Beverage | In-kind items and services | $1.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | ONGLYZA (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/04/2024 | Eisai Inc. | — | Food and Beverage | In-kind items and services | $122.29 | General |
| 05/30/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2024 | Eisai Inc. | Lenvima (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,037.50 | General |
| Category: Oncology | ||||||
| 05/21/2024 | Eisai Inc. | Lenvima (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $815.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 37 | 55 | $14,985 | $6,150 |
| 2022 | 2 | 34 | 39 | $10,926 | $4,494 |
| 2021 | 1 | 24 | 30 | $7,244 | $3,455 |
| 2020 | 1 | 12 | 12 | $9,480 | $1,707 |
Total Patients
107
Total Services
136
Medicare Billing
$15,806
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 35 | $10,465 | $4,288 | 41.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 20 | $4,520 | $1,861 | 41.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 22 | 27 | $6,534 | $2,956 | 45.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 12 | 12 | $4,392 | $1,538 | 35.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 24 | 30 | $7,244 | $3,455 | 47.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $9,480 | $1,707 | 18.0% |
About Dr. Gregory Gressel, M.D
Dr. Gregory Gressel, M.D is a Gynecologic Oncology healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2011. The National Provider Identifier (NPI) number assigned to this provider is 1972895092.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Gressel, M.D has received a total of $59,706 in payments from pharmaceutical and medical device companies, with $39,774 received in 2024. These payments were reported across 70 transactions from 11 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a medical education program" ($26,691).
As a Medicare-enrolled provider, Gressel has provided services to 107 Medicare beneficiaries, totaling 136 services with total Medicare billing of $15,806. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Other Specialties Obstetrics & Gynecology
- Location Grand Rapids, MI
- Active Since 05/08/2011
- Last Updated 06/03/2025
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1972895092
Products in Payments
- Lenvima (Drug) $34,682
- ZEJULA (Drug) $13,099
- TIVDAK (Biological) $3,832
- ENHERTU (Biological) $3,425
- JEMPERLI (Biological) $473.96
- LYNPARZA (Drug) $309.20
- ELAHERE (Drug) $205.46
- FLOSEAL (Device) $90.79
- SEPRAFILM (Device) $42.38
- ONGLYZA (Drug) $24.74
- Rubraca (Drug) $20.01
- myChoice CDx (Device) $19.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in Grand Rapids
Dr. Leigh Seamon, D.o, D.O
Gynecologic Oncology — Payments: $3,349
Gynecologic Oncology $3,349
Dr. Mae Zakhour
Gynecologic Oncology — Payments: $3,069
Gynecologic Oncology $3,069
Dr. Christopher Hummel, D.o, D.O
Gynecologic Oncology — Payments: $956.47
Gynecologic Oncology $956.47
Dr. Andrea Buras, M.d, M.D
Gynecologic Oncology — Payments: $882.04
Gynecologic Oncology $882.04
Dr. Charles Harrison, Md, MD
Gynecologic Oncology — Payments: $743.16
Gynecologic Oncology $743.16
Margaret Whicker, M.d, M.D
Gynecologic Oncology — Payments: $244.36
Gynecologic Oncology $244.36